More Rhythm Biosciences Limited news
Rhythm Biosciences LimitedASX: RHY

S&P DJI Announces March 2024 Quarterly Rebalance

Mar 1, 2024 at 6:24 AM EST · Issued by Rhythm Biosciences Limited

Filed with ASX · Mar 1, 2024 at 6:24 AM EST · 8 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2024-quarterly-rebalance-91

Rhythm Biosciences Limited on 6ix

Story so far

  • S&P DJI Announces March 2022 Quarterly RebalanceMar 4, 2022

Earlier from Rhythm Biosciences

  • Half Yearly Report and AccountsFeb 28, 2024
  • Prospectus - 2024 Non-Renounceable Rights IssueFeb 18, 2024
  • Rights Issue Offer to Raise Up To $6.6 millionFeb 8, 2024
  • Quarterly Activities Report and Appendix 4C - Dec23Jan 30, 2024
  • Strategy & Market UpdateDec 17, 2023

Later from Rhythm Biosciences

  • Internationally Renowned Clinical Advisory Board EstablishedMar 18, 2024
  • Close of Rights IssueMar 20, 2024
  • Rhythm Maintains ISO CertificationApr 22, 2024
  • Dr David Atkins appointed Chief Executive Officer of RhythmApr 24, 2024
  • Mar24 Quarterly Activities Report and Appendix 4CApr 29, 2024
All Rhythm Biosciences news releases↗

Follow Rhythm Biosciences into a list and get an email when it puts out news.

Follow Rhythm Biosciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer